Christopher Johnson
Sports Medicine · Tempe, AZNPI 1295459063
Payments from drug & device makers
Across 105 payments — averaging $21.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$353
- Pfizer$269
- Eisai Inc.$267
- Boehringer Ingelheim$134
- Amgen$121
- GSK$105
- plus $969 from 19 others
What the payments were for
- Food & beverage$2,218100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $353 |
| Pfizer | 13 | $269 |
| Eisai Inc. | 9 | $267 |
| Boehringer Ingelheim | 6 | $134 |
| Amgen | 6 | $121 |
| GSK | 5 | $105 |
| Bioventus LLC | 2 | $90 |
| Novo Nordisk | 5 | $89 |
| Abbott | 4 | $86 |
| Exact Sciences | 4 | $73 |
| AstraZeneca | 4 | $68 |
| Lilly USA, LLC | 3 | $63 |
| Fidia Pharma USA Inc. | 3 | $63 |
| Johnson & Johnson(2 entities) | 3 | $55 |
| Astellas Pharma US Inc | 2 | $52 |
| Merck | 2 | $47 |
| Boston Scientific | 2 | $43 |
| Corcept Therapeutics | 2 | $39 |
| Tolmar, Inc. | 2 | $38 |
| Novartis | 2 | $35 |
| Lundbeck LLC | 1 | $30 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
How this compares
$2,218 in reported general payments places this provider in the 55th percentile of 152 sports medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $11,574 |
| Fenofibrate | 24 | $1,092 |
| Tamsulosin Hcl | 44 | $715 |
| Testosterone Cypionate | 13 | $686 |
| SynthroidLevothyroxine Sodium | 11 | $587 |
| Gabapentin | 22 | $577 |
| Atorvastatin Calcium | 55 | $500 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $480 |
| Rosuvastatin Calcium | 58 | $420 |
| Ropinirole Hcl | 11 | $342 |
| Allopurinol | 14 | $335 |
| Pantoprazole Sodium | 20 | $302 |
| Losartan Potassium | 42 | $291 |
| Duloxetine Hcl | 16 | $287 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $285 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $269 | $11,57415 claims |
| AbbVieSynthroid | $353 | $58711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 152 sports medicine providers in Arizona.
Other sports medicine in Tempe
- Thomas FielTempe$23.5M
- Anup ShahPhoenix$1.5M
- Amon FerryScottsdale$752K
- John TokishScottsdale$611K
- Eric EiflerChandler$342K
- John BrownSun City West$289K
- Shelden MartinChandler$208K
- Kyle ChunPrescott Valley$160K
- Matthew HansenGilbert$84K
- Jeffrey AbildgaardGilbert$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.